HuGE Literature Finder
|
||
Records 1-12
|
Prognostic Value of TERT Alterations and Mutational and Copy Number Alteration Burden in Urothelial Carcinoma.
European urology focus 2017 Aug . Isharwal Sumit, Audenet François, Drill Esther, Pietzak Eugene J, Iyer Gopa, Ostrovnaya Irina, Cha Eugene, Donahue Timothy, Arcila Maria, Jayakumaran Gowtham, Berger Michael F, Rosenberg Jonathan E, Bajorin Dean F, Coleman Jonathan, Dalbagni Guido, Reuter Victor E, Bochner Bernard H, Solit David B, Al-Ahmadie Hikmat |
|
Potential Susceptibility Loci Identified for Renal Cell Carcinoma by Targeting Obesity-related Genes.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2017 Jun . Shu Xiang, Purdue Mark P, Ye Yuanqing, Tu Huakang, Wood Christopher G, Tannir Nizar M, Wang Zhaoming, Albanes Demetrius, Gapstur Susan M, Stevens Victoria L, Rothman Nathaniel, Chanock Stephen J, Wu Xife |
|
Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets.
Nature communications 2016 Oct 7 13131. Chen Ying-Bei, Xu Jianing, Skanderup Anders Jacobsen, Dong Yiyu, Brannon A Rose, Wang Lu, Won Helen H, Wang Patricia I, Nanjangud Gouri J, Jungbluth Achim A, Li Wei, Ojeda Virginia, Hakimi A Ari, Voss Martin H, Schultz Nikolaus, Motzer Robert J, Russo Paul, Cheng Emily H, Giancotti Filippo G, Lee William, Berger Michael F, Tickoo Satish K, Reuter Victor E, Hsieh James |
|
Do patients with tuberous sclerosis complex have an increased risk for malignancies?
American journal of medical genetics. Part A 2016 Apr . Peron Angela, Vignoli Aglaia, La Briola Francesca, Volpi Angela, Montanari Emanuele, Morenghi Emanuela, Ghelma Filippo, Bulfamante Gaetano, Cefalo Graziella, Canevini Maria Pao |
|
Mutations in TSC1, TSC2, and MTOR are associated with response to rapalogs in patients with metastatic Renal Cell Carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2016 Feb . Kwiatkowski David J, Choueiri Toni K, Fay Andre P, Rini Brian I, Thorner Aaron R, De Velasco Guillermo, Tyburczy Magdalena, Hamieh Lana, Albiges Laurence, Agarwal Neeraj, Ho Thai H, Song Jiaxi, Pignon Jean-Christophe, Barrios Pablo M, Michaelson M Dror, Van Allen Eliezer M, Krajewski Katherine M, Porta Camillo, Pal Sumanta Kumar, Bellmunt Joaquim, McDermott David F, Heng Daniel Y C, Gray Kathryn P, Signoretti Sabi |
|
Mutational landscape of MCPyV-positive and MCPyV-negative merkel cell carcinomas with implications for immunotherapy.
Oncotarget 2015 Dec . Goh Gerald, Walradt Trent, Markarov Vladimir, Blom Astrid, Riaz Nadeem, Doumani Ryan, Stafstrom Krista, Moshiri Ata, Yelistratova Lola, Levinsohn Jonathan, Chan Timothy A, Nghiem Paul, Lifton Richard P, Choi Jaehy |
|
Genetic variations in STK11, PRKAA1, and TSC1 associated with prognosis for patients with colorectal cancer.
Annals of surgical oncology 2014 Dec 21 Suppl 4 S634-9. Lee Soo Jung, Kang Byung Woog, Chae Yee Soo, Kim Hye Jin, Park Su Yeon, Park Jun Seok, Choi Gyu Seog, Jeon Hyo-Sung, Lee Won Kee, Kim Jong Gwa |
|
Advanced urothelial carcinoma: next-generation sequencing reveals diverse genomic alterations and targets of therapy.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2014 Feb 27 (2): 271-80. Ross Jeffrey S, Wang Kai, Al-Rohil Rami N, Nazeer Tipu, Sheehan Christine E, Otto Geoff A, He Jie, Palmer Gary, Yelensky Roman, Lipson Doron, Ali Siraj, Balasubramanian Sohail, Curran John A, Garcia Lazlo, Mahoney Kristen, Downing Sean R, Hawryluk Matthew, Miller Vincent A, Stephens Philip |
|
Polymorphic variants in TSC1 and TSC2 and their association with breast cancer phenotypes.
Breast cancer research and treatment 2011 Feb 125 (3): 861-8. Mehta Madhura S, Vazquez Alexei, Kulkarni Diptee A, Kerrigan John E, Atwal Gurinder, Metsugi Shoichi, Toppmeyer Deborah L, Levine Arnold J, Hirshfield Kim |
|
A systematic study of gene mutations in urothelial carcinoma; inactivating mutations in TSC2 and PIK3R1.
PloS one 2011 6 (4): e18583. Sjödahl Gottfrid, Lauss Martin, Gudjonsson Sigurdur, Liedberg Fredrik, Halldén Christer, Chebil Gunilla, Månsson Wiking, Höglund Mattias, Lindgren Dav |
|
Genetic variability of the mTOR pathway and prostate cancer risk in the European Prospective Investigation on Cancer (EPIC).
PloS one 2011 6 (2): e16914. Campa Daniele, Hüsing Anika, Stein Angelika, Dostal Lucie, Boeing Heiner, Pischon Tobias, Tjønneland Anne, Roswall Nina, Overvad Kim, Østergaard Jane Nautrup, Rodríguez Laudina, Sala Núria, Sánchez Maria-José, Larrañaga Nerea, Huerta José María, Barricarte Aurelio, Khaw Kay-Tee, Wareham Nicholas, Travis Ruth C, Allen Naomi E, Lagiou Pagona, Trichopoulou Antonia, Trichopoulos Dimitrios, Palli Domenico, Sieri Sabina, Tumino Rosario, Sacerdote Carlotta, van Kranen Henk, Bueno-de-Mesquita H Bas, Hallmans Göran, Johansson Mattias, Romieu Isabelle, Jenab Mazda, Cox David G, Siddiq Afshan, Riboli Elio, Canzian Federico, Kaaks Rudo |
|
A Large-scale genetic association study of esophageal adenocarcinoma risk.
Carcinogenesis 2010 Jul 31 (7): 1259-63. Liu Chen-Yu, Wu Michael C, Chen Feng, Ter-Minassian Monica, Asomaning Kofi, Zhai Rihong, Wang Zhaoxi, Su Li, Heist Rebecca S, Kulke Matthew H, Lin Xihong, Liu Geoffrey, Christiani David |
- Page last reviewed:Mar 1, 2018
- Page last updated:Jul 18, 2019
- Content source: